Mesothelin Expression in the Leptomeninges and Meningiomas
Mahlon D. Johnson 1*, Fran Vito 1 and Mary J. O’Connell 1
1 Division of Neuropathology, Department of Pathology, University of Rochester Medical Center, Rochester, New York
* To whom correspondence should be addressed. E-mail: mahlon_johnson{at}urmc.rochester.edu.
Submitted on January 14, 2008
Accepted on 28 February 2008
 |
Abstract |
|---|
The identity and functions of surface proteins on human leptomeningeal and meningioma cells are incompletely characterized. Some structural and functional similarities between the leptomeninges and pleura suggest that proteins important to pleural function and tumorigenesis might also be relevant to leptomeningeal disease. Mesothelin is a recently described, 40kDa membrane protein expressed in pleura. Its functions in this tissue are under investigation. Sections of 20 normal adult brains with leptomeninges, 49 World Health Organization (WHO) grade I, 21 grade II and 2 grade III meningiomas were analyzed using an extensively characterized monoclonal antibody to mesothelin and streptavidin-biotin complex immunohistochemistry. Five meningiomas were also evaluated by Western blot. Mesothelin-immunoreactivity was detected in the arachnoid in 6 of 20 cases and in 23 of 49 WHO grade I meningiomas. It was also detected in 7 of 21 WHO II tumors and one of the 2 anaplastic meningiomas. By Western blot, all 5 meningiomas exhibited mesothelin precursor protein including one where notable immunoreactivity was not identified in a formalin-fixed tissue section. These findings suggest that mesothelin is expressed in at least some arachnoid and meningioma cells. Future studies may clarify its role in the development of meningiomas, meningeal seeding of gliomas and metastases to the leptomeninges.
Key Words:
mesothelin, meningioma, leptomeninges, arachnoid
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?